Pomerantz WCK[Author] - Search Results

Year	Number of Results
2015	3
2016	6
2017	7
2018	3
2019	5
2020	10
2021	1

1

Endothelial p300 promotes portal hypertension and hepatic fibrosis through CCL2-mediated angiocrine signaling.

Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, Hu X, Xue F, Yaqoob U, Kang N, Cui H, Pomerantz WCK, Kostallari E, Shah VH. Gao J, et al. Among authors: pomerantz wck. Hepatology. 2020 Nov 7. doi: 10.1002/hep.31617. Online ahead of print. Hepatology. 2020. PMID: 33159815

2

SAR by (Protein-Observed) ¹⁹F NMR.

Divakaran A, Kirberger SE, Pomerantz WCK. Divakaran A, et al. Among authors: pomerantz wck. Acc Chem Res. 2019 Dec 17;52(12):3407-3418. doi: 10.1021/acs.accounts.9b00377. Epub 2019 Nov 13. Acc Chem Res. 2019. PMID: 31718149 Review.

3

Multidimensional Nanoparticle Characterization through Ion Mobility-Mass Spectrometry.

Li C, Lee AL, Chen X, Pomerantz WCK, Haynes CL, Hogan CJ Jr. Li C, et al. Among authors: pomerantz wck. Anal Chem. 2020 Feb 4;92(3):2503-2510. doi: 10.1021/acs.analchem.9b04012. Epub 2020 Jan 21. Anal Chem. 2020. PMID: 31913020

4

Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors.

Carlson AS, Cui H, Divakaran A, Johnson JA, Brunner RM, Pomerantz WCK, Topczewski JJ. Carlson AS, et al. Among authors: pomerantz wck. ACS Med Chem Lett. 2019 Aug 2;10(9):1296-1301. doi: 10.1021/acsmedchemlett.9b00227. eCollection 2019 Sep 12. ACS Med Chem Lett. 2019. PMID: 31531200 Free PMC article.

5

Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains.

Johnson JA, Nicolaou CA, Kirberger SE, Pandey AK, Hu H, Pomerantz WCK. Johnson JA, et al. Among authors: pomerantz wck. ACS Med Chem Lett. 2019 Nov 22;10(12):1648-1654. doi: 10.1021/acsmedchemlett.9b00414. eCollection 2019 Dec 12. ACS Med Chem Lett. 2019. PMID: 31857841 Free PMC article.

6

Efficient Synthesis of 1,4-Thiazepanones and 1,4-Thiazepanes as 3D Fragments for Screening Libraries.

Pandey AK, Kirberger SE, Johnson JA, Kimbrough JR, Partridge DKD, Pomerantz WCK. Pandey AK, et al. Among authors: pomerantz wck. Org Lett. 2020 May 15;22(10):3946-3950. doi: 10.1021/acs.orglett.0c01230. Epub 2020 Apr 29. Org Lett. 2020. PMID: 32347732

7

Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor.

Kirberger SE, Ycas PD, Johnson JA, Chen C, Ciccone MF, Woo RWL, Urick AK, Zahid H, Shi K, Aihara H, McAllister SD, Kashani-Sabet M, Shi J, Dickson A, Dos Santos CO, Pomerantz WCK. Kirberger SE, et al. Among authors: pomerantz wck. Org Biomol Chem. 2019 Feb 13;17(7):2020-2027. doi: 10.1039/c8ob02599a. Org Biomol Chem. 2019. PMID: 30706071 Free PMC article.

8

2-Fluorotyrosine is a valuable but understudied amino acid for protein-observed ¹⁹F NMR.

Ycas PD, Wagner N, Olsen NM, Fu R, Pomerantz WCK. Ycas PD, et al. Among authors: pomerantz wck. J Biomol NMR. 2020 Jan;74(1):61-69. doi: 10.1007/s10858-019-00290-0. Epub 2019 Nov 23. J Biomol NMR. 2020. PMID: 31760571

9

Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement*.

Cui H, Divakaran A, Pandey AK, Johnson JA, Zahid H, Hoell ZJ, Ellingson MO, Shi K, Aihara H, Harki DA, Pomerantz WCK. Cui H, et al. Among authors: pomerantz wck. Angew Chem Int Ed Engl. 2021 Jan 18;60(3):1220-1226. doi: 10.1002/anie.202008625. Epub 2020 Nov 18. Angew Chem Int Ed Engl. 2021. PMID: 32975004

10

New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.

Ycas PD, Zahid H, Chan A, Olson NM, Johnson JA, Talluri SK, Schonbrunn E, Pomerantz WCK. Ycas PD, et al. Among authors: pomerantz wck. Org Biomol Chem. 2020 Jul 15;18(27):5174-5182. doi: 10.1039/d0ob00506a. Org Biomol Chem. 2020. PMID: 32588860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results